Aurinia Pharmaceuticals Cash Flow Statement (2014-2025) | AUPH

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Mar2014	Jun2014	Sep2014	Dec2014	Mar2015	Jun2015	Sep2015	Mar2018	Jun2018	Sep2018	Dec2018	Mar2019	Jun2019	Sep2019	Dec2019	Mar2020	Jun2020	Sep2020	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025
Operating Activities
Net Income			0.00B	-0.00B				-0.02B	-0.02B	0.02B	-0.01B	-0.01B	-0.02B	-0.02B	-0.08B	-0.03B	-0.03B	-0.04B	-0.05B	-0.05B	-0.05B	-0.03B	-0.04B	-0.04B	-0.01B	-0.03B	-0.03B	-0.01B	-0.01B	-0.03B	-0.01B	0.00B	0.01B	0.00B	0.02B	0.02B	0.03B
Depreciation and Depletion		0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	-0.00B	0.00B	0.00B	0.00B	-0.00B	0.00B	0.00B	0.01B	-0.01B	0.00B	0.00B	0.00B	-0.01B
Share-based Compensation		0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.01B			0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	-0.00B	0.01B	0.01B
Gains from Investment Securities		0.00B	-0.00B	-0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	-0.00B	0.00B	0.00B	-0.01B	-0.00B	0.00B	-0.17B	0.01B				-0.00B	-0.00B	0.00B	0.00B	-0.00B	0.00B	-0.00B	0.09B	0.01B	0.00B	0.00B	0.00B	0.01B	0.01B	0.00B
Asset Writedowns and Impairment																						0.00B				0.00B
Non-cash Items		-0.00B	-0.00B		-0.00B	-0.01B	-0.01B	0.01B	0.01B	0.01B	-0.08B	0.01B	0.01B	0.02B	-0.11B	-0.02B	-0.02B	-0.04B
Change in Working Capital				0.03B
Change in Receivables																			0.00B	0.00B	0.01B	0.01B	0.00B	-0.00B	0.02B	-0.03B	0.01B	0.00B	0.02B	-0.01B	0.00B	-0.00B	0.01B	0.00B	0.00B	-0.00B	-0.01B
Change in Inventory																			0.00B	0.00B	0.00B	0.00B	0.01B	0.00B	0.00B	0.00B	0.01B	0.00B	0.00B	0.01B	0.00B	-0.00B	-0.00B	0.00B	0.01B	0.00B	-0.00B
Change in Account Payables																															0.00B	0.00B	0.00B	-0.00B	-0.00B	-0.00B	-0.00B
Change in Accured Expenses																0.00B			-0.01B	0.01B	0.00B	0.00B	-0.01B	0.00B	0.01B	0.00B	-0.00B	0.01B	0.01B	0.00B	-0.01B	0.00B	-0.00B	0.02B	-0.02B	0.01B	-0.00B
Other Working Capital Changes		-0.00B	-0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	-0.00B	0.00B	0.01B	0.00B	0.00B	0.01B	-0.01B	0.01B	0.01B	0.01B	0.00B			-0.00B	-0.00B	0.01B	-0.00B	-0.00B	-0.00B	0.00B	0.01B	-0.01B	-0.00B	0.01B	0.00B	-0.00B	-0.01B	0.01B	-0.00B
Cash from Operations	-5.35B	-0.00B	-0.00B	0.03B	0.00B	-0.00B	-0.01B		0.01B		-0.04B								-0.05B	-0.04B	-0.04B	-0.03B	-0.05B	-0.03B	-0.02B	0.01B	-0.03B	-0.00B	-0.01B	0.01B	-0.02B	0.02B	0.02B	0.03B	0.00B	0.04B	0.04B
Depreciation, Depletion & Amortization
Amortizatization of Intangibles		-0.00B	-0.00B	0.00B	0.00B	-0.00B	-0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	-0.00B	0.00B	0.00B	-0.00B	0.00B	-0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Amortization		-0.00B	0.00B	0.00B	0.01B	-0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.15B	0.02B	0.03B	0.31B	-0.02B	0.46B
Depreciation & Amortization (CF)		0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	-0.00B	0.00B	0.00B	0.00B	-0.00B	0.00B	0.00B	0.01B	-0.01B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Investing Activities
Capital Expenditures		-0.00B	-0.00B		0.00B	-0.00B		0.00B			0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	-0.00B	-0.00B	0.00B				0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	-0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Change in Intangibles		-0.00B	-0.00B	0.00B	-0.00B	-0.00B	-0.00B		-0.00B		-0.00B	0.00B		0.00B		0.00B	-0.00B	-0.00B	0.00B			-0.00B					0.00B	0.00B	0.00B		0.00B	0.00B	0.00B
Divestments		-0.00B	-0.01B	-10.07B	-0.00B	-0.00B	0.00B
Change in Acquisitions & Divestments			-0.01B	0.02B	0.01B	-0.00B	-0.01B	-0.02B		-0.02B	0.07B						-0.02B		0.06B		0.10B	0.09B	0.11B	0.12B	0.12B	0.12B	0.17B	0.12B	0.10B	0.14B	0.17B	0.16B	0.13B	0.12B	0.12B	0.13B	0.09B
Cash from Investing Activities		-0.00B	-0.01B	0.02B	-0.00B	-0.00B	0.00B		0.01B		-0.00B								-0.07B	0.00B	-0.03B	-0.01B	-0.05B	0.05B	-0.05B	-0.00B	0.02B	-0.01B	-0.02B	-0.01B	0.05B	-0.04B	-0.01B	0.04B	0.03B	-0.01B	-0.01B
Financing Activities
Cash from Financing Activities	46.84B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B		0.00B		0.00B								0.01B	0.00B	0.01B	0.21B	0.00B	0.00B		0.00B	0.00B	0.00B	-0.00B	-0.01B	-0.02B	-0.01B	-0.00B	-0.02B	-0.05B	-0.04B	-0.01B
Additional items
Exchange Rate Effect	-0.01B	0.00B	-0.00B	-0.00B
Change in Cash	41.47B	-0.00B	-0.01B	20.86B	0.00B	-0.00B	-0.01B		0.00B		-0.04B								-0.12B	-0.04B	-0.06B	0.17B	-0.10B	0.02B	-0.07B	0.01B	-0.01B	-0.01B	-0.04B	0.00B	0.02B	-0.03B	0.00B	0.05B	-0.02B	-0.01B	0.02B
Free Cash Flow	-5.35B	-0.00B	-0.00B	0.03B	0.00B	-0.00B	-0.01B	-0.00B	0.01B		-0.04B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	0.00B	0.00B	-0.05B	-0.04B	-0.04B	-0.03B	-0.05B	-0.03B	-0.02B	0.01B	-0.03B	-0.00B	-0.01B	0.01B	-0.02B	0.02B	0.02B	0.03B	0.00B	0.04B	0.04B
Net Cash Flow	41.48B	-0.00B	-0.01B	0.05B	0.00B	-0.00B	-0.01B		0.03B		-0.04B								-0.12B	-0.04B	-0.06B	0.17B	-0.10B	0.02B	-0.07B	0.01B	-0.01B	-0.01B	-0.04B	0.00B	0.02B	-0.03B	0.00B	0.05B	-0.02B	-0.01B	0.02B

Research Tools

Aurinia Pharmaceuticals Cash Flow Statement (2014-2025) | AUPH

Create an account

Sign In

Reset Password